Administration of human chorionic gonadotropin with a controlled-release function to immature rats for application in male infertility therapy

Citation
K. Okabe et al., Administration of human chorionic gonadotropin with a controlled-release function to immature rats for application in male infertility therapy, DRUG DEV IN, 26(5), 2000, pp. 559-562
Citations number
13
Categorie Soggetti
Pharmacology & Toxicology
Journal title
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
ISSN journal
03639045 → ACNP
Volume
26
Issue
5
Year of publication
2000
Pages
559 - 562
Database
ISI
SICI code
0363-9045(2000)26:5<559:AOHCGW>2.0.ZU;2-Z
Abstract
Biodegradable poly(or-lactic acid) (PLA) devices with controlled release of human chorionic gonadotropin (hCG) were fabricated in a 2-mm cylinder form by the melt-pressing technique. The devices fabricated were inserted subcu taneously in the backs of immature rats. It was found that the serum level of testosterone (T) remained constant at approximately 0.7 ng/ml for an exp erimental period of 14 days, resulting in greater Leydig cell production of testosterone. This was also suggested from the results of immunohistochemi cal observation of the testis and weight changes of prostates, such as the ventral prostates and seminal vesicle.